



PERSONALITY DIFFICULTIES AND RESPONSE TO COMMUNITY-BASED PSYCHOLOGICAL TREATMENT 
FOR ANXIETY AND DEPRESSION 
 
ABSTRACT  
Background: Previous research suggests that comorbid personality disorder may be associated with 
a less favourable treatment outcome for individuals with depression and anxiety disorder. However, 
little is known about whether personality difficulties are associated with treatment outcomes within 
Improving Access to Psychological Therapies (IAPT) services-the largest platform for treating 
depression and anxiety in England, UK. Secondary aims were to investigate i) whether individual 
personality difficulties are associated with treatment outcome and ii) whether findings are 
moderated by treatment type.  
 
Methods: The sample included 3,689 adults who accessed community-based psychological 
treatment (cognitive behavioural therapy, emotional skills training, or other psychological therapy) 
for depression and/or anxiety disorder. Associations between personality difficulties (assessed with 
the Standardised Assessment of Personality–Abbreviated Scale (SAPAS)) and treatment outcomes 
(recovery and reliable improvement in depression/anxiety symptom scores, assessed using 
questionnaire-based measures) were investigated using logistic/linear regression.  
 
Results: Personality difficulties were associated with a reduced likelihood of recovery (adjusted OR 
per unit increase on SAPAS: depression=0.87, 95%CI 0.84, 0.91; anxiety=0.86, 95%CI 0.82, 0.90) and 
reliable improvement (adjusted OR per unit increase on SAPAS: depression=0.88, 95%CI 0.84, 0.92; 
anxiety=0.85, 95%CI 0.82, 0.89).. Those with three or more difficulties were over 30% less likely to 





Limitations: Personality difficulties data were collected via self-report and were not available for all 
participants.   
 
Conclusion: Patients with personality difficulties have a less favourable response to psychological 
treatment for depression/anxiety disorder. If replicated, the findings highlight a major challenge to 
the way community-based psychological therapy services in England (IAPT services) are presently 
constituted.  
 









Depression and anxiety disorders can have a devastating impact on the functioning and quality of life 
of individuals, and are associated with an increased risk of suicide (Arsenault-Lapierre et al., 2004, 
Kessler et al., 2014, Bandelow and Michaelis, 2015). Guidelines, such as the National Institute for 
Health and Care Excellence (NICE), recommend psychological therapies, such as cognitive 
behavioural therapy (CBT), as an intervention (National Institute for Health and Clinical Excellence, 
2011), however, for many patients, timely access to appropriate psychological treatment is limited 
(Thornicroft et al., 2017, Bandelow and Michaelis, 2015). To help address the increasing burden of 
common mental health problems in the UK, the Improving Access to Psychological Therapies (IAPT) 
programme was introduced in England in 2008. IAPT provides evidence-based psychological 
therapies to people in the community with depression and anxiety disorders. It is recognised as one 
of the most ambitious programmes of psychological therapies in the world, and currently receives 
over 1.4 million referrals per annum  (Health & Social Care Information Centre, 2018). In IAPT 
services, the most commonly delivered treatment is CBT, however other psychological treatments 
are also available; for example emotional skills training, brief cognitive analytic therapy, or 
interpersonal therapy.  
Two of IAPT’s key performance indicators are ‘recovery’, defined as an individual moving 
from a ‘case’ at pre-treatment to a ‘non-case’ at the end of therapy (based on recommended cut-
points on self-reported measures of depression and anxiety) and ‘reliable improvement’ (i.e. 
minimum improvement) in symptom scores (The National Collaborating Centre for Mental Health, 
2018). However, only half of patients recover and around two thirds achieve reliable improvement 
(Health & Social Care Information Centre, 2018). Identifying the factors that predict an individual’s 
response to treatment would have important implications for clinical practice and could lead to 
improved tailoring of services and improved outcomes for patients. It has been suggested that the 
presence of co-morbid personality disorder can lead to less favourable treatment outcomes for 




et al., 1994, Hansen et al., 2007, Steketee et al., 2001, Telch et al., 2011, Goddard et al., 2015, 
Newton-Howes et al., 2014). However, findings are mixed, with some studies reporting no 
association (Kampman et al., 2008, Joyce et al., 2007, van Bronswijk et al., 2018).  
The assessment of personality disorder is lengthy and requires training. In order to allow 
non-specialists and researchers to rapidly screen for personality disorder, screening tools, such as 
the Standardized Assessment of Personality - Abbreviated Scale (SAPAS) have therefore been 
developed. The SAPAS is an 8-item measure refined from the Standardized Assessment of 
Personality (Mann et al, 1981) which assesses eight core features of PD as described in the ICD-11 
and DSM-V, referred to in this paper as ‘personality difficulties’. Personality difficulties, as measured 
by the SAPAS, such as extreme impulsivity or lack of trust, underlie the concept of personality 
disorder (Morey et al., 2016). Furthermore, other research has shown that the SAPAS captures 
specific variance associated with personality disorder, as opposed to the variance associated with 
the “Big Five” personality trait dimensions(Ball et al., 2017). Knowledge of whether there is a 
relationship between the number of personality difficulties and the effectiveness of treatment for 
depression and anxiety disorders offered by community-based services such as IAPT is limited. This is 
an important knowledge gap, as IAPT is the largest platform for treating depression and anxiety 
disorders in England, and personality difficulties appear to be relatively common among IAPT 
attenders (Hepgul et al., 2016). Little is also known about the impact of personality difficulties on 
other key treatment outcomes such as social functioning. This study addressed these knowledge 
gaps in a in a large sample of patients attending an English IAPT service. The aims of the study were 
to: 
1) Investigate whether levels of personality difficulties were associated with treatment 
response, including recovery and reliable improvement/deterioration in symptoms of 
depression and anxiety (adjusting for baseline symptom severity).  
2) Investigate whether levels of personality difficulties were associated with change in 




3) Identify whether treatment outcomes were differentially associated with different 
personality difficulties.  
4) Explore whether associations with treatment outcomes were moderated by the type of 






Design and participants 
We conducted an analysis of data obtained from an existing clinical register of IAPT attendees. The 
sample included adult patients (>18 years) who had accessed the Somerset Partnership NHS 
Foundation Trust IAPT service for treatment of common mental disorder (depression/anxiety 
disorders) between 1st November 2012 (when assessment of personality difficulties was first 
instituted across the service) and 30th April 2018. If a patient presented on more than one occasion 
during the study period, then only the first instance was included. The Trust has a catchment 
population of 544,000 and performance levels are slightly higher than the national average with a 
recovery rate of 56%.  
Within IAPT services the most common treatment for depression and anxiety disorders is 
Cognitive Behavioural Therapy (CBT), however a range of other evidence-based psychological 
therapies for depression and anxiety disorders are also provided. Treatment is allocated in line with 
a stepped-care model, which works according to the principle that individuals should be offered the 
least intrusive treatment appropriate for their needs (The National Collaborating Centre for Mental 
Health, 2018). Patients with mild-moderate symptoms of depression may receive low-intensity 
treatments first (such as guided self-help or computerised CBT), whereas those with moderate-
severe symptoms of depression may receive high-intensity psychological interventions (such as CBT), 
delivered by a trained therapist. It is likely that those allocated to high and low intensity treatments 
differ in important ways including severity of depression/anxiety symptoms, number of personality 
difficulties, as well as duration and type of therapy received.  We therefore restricted our analysis to 
those who were allocated to high intensity treatment in order to ensure a more homogenous 
treatment sample (N=9,149). Treatments received included i) CBT, ii) Emotional Skills Training (EST) 
(an 8-week emotional skills group program informed by dialectical behaviour therapy), and iii) other 
psychological therapy (PT) (includes: brief cognitive analytic therapy; humanistic /integrative 




interpersonal therapy). Data on personality difficulties was available for 4,733/9149 patients 
(51.7%). Those with data recorded on personality difficulties were more likely to be female and to be 
older than those without. They also differed with regards to their presenting problem, with a higher 
prevalence of ‘mixed depression and anxiety’ and ‘other’ diagnosis (Supplementary Table 1). No 
differences were found for ethnicity or deprivation score.   
The analytical sample was restricted to patients who had the same initial assessment date 
for depression and anxiety symptoms (N=3,819). The small number of patients who had data on 
personality difficulties recorded outside the treatment episode were excluded (N=130) resulting in a 
final analytic sample of 3,689.  
 
Ethical approval  
The authors assert that all procedures contributing to this work comply with the ethical standards of 
the relevant national and institutional committees on human experimentation and with the Helsinki 
Declaration of 1975, as revised in 2008. All procedures involving human subjects/patients were 
approved by the University of Bristol (ref: 62789), and the UK Health Research Authority (IRAS 
project ref: 229218)  
 
Measures  
The IAPT service follows a standardised protocol and information on symptoms and functional 
outcomes is routinely collected at each treatment session using validated questionnaire measures 
(The National Collaborating Centre for Mental Health, 2018). These are not diagnostic tools but 
demonstrate good diagnostic specificity when compared with clinical interview measures and are 
routinely used in Health Care settings in the UK. All patients consented to their anonymised 
information being stored on an electronic database and used for evaluation purposes.   
 




Personality difficulties were assessed using the Standardised Assessment of Personality – 
Abbreviated Scale (SAPAS) (Moran et al., 2003). The SAPAS is an eight-item screen for personality 
disorder and each item is rated using a dichotomous yes/no format. The total score ranges from 0-8 
with higher scores indicating higher likelihood of the presence of personality disorder. The SAPAS 
has been validated in both clinical (Moran et al, 2003) and population-based samples (Ball et al, 
2017; Fok et al, 2015) as well as patients with depression (Bukh et al, 2010; Gorwood et al, 2010). In 
clinical samples, a score of 3 or more has been found to correctly identify personality disorder in 
90% of patients, with a sensitivity of 0.94 and specificity of 0.85 (Moran et al., 2003). The internal 
consistency of the SAPAS in the IAPT sample was 0.6, a level consistent with that found in other 
studies(Fok et al., 2015). As it took time to implement the SAPAS measure into routine practice, it 
was not recorded at the first assessment for all patients. The proportion who had a SAPAS score 
recorded at baseline was 30% (N=1,102). 
 
Outcome measures  
1) Engagement with treatment      
A binary variable was created indicating whether participants completed the minimum number of 
treatment sessions, defined, per service guidelines, as two or more sessions of CBT/PT and four or 
more sessions of EST.  
 
2) Depressive symptoms (assessed at initial assessment and at last clinical contact)  
Depressive symptoms were assessed using the Patient Health Questionnaire (PHQ-9) (Kroenke and 
Spitzer, 2002). This is a validated nine-item questionnaire based on the DSM-IV criteria for major 
depressive disorder and is used to monitor the severity of depression symptoms and response to 
treatment within IAPT services. It has been shown to be a reliable and valid measure of major 
depression (Kroenke et al., 2001). Each item is scored from “0" (not at all) to "3" (nearly every day). 




score of 10 or more is used as a cut-off to identify clinical caseness. Patients were classified as 
‘recovered’ if their PHQ-9 scores were above the clinical cut-off at the initial assessment and below 
the clinical cut-off at the last assessment. A change of 6 or more indicates reliable 
improvement/deterioration in depression symptoms. The internal consistency of the PHQ-9 in the 
IAPT sample was 0.8.   
 
3) Anxiety symptoms (assessed at initial assessment and at last clinical contact) 
Anxiety symptoms were assessed using the Generalised Anxiety Disorder Assessment (GAD-7) 
(Spitzer et al., 2006). This is a seven-item questionnaire used as a screening tool and severity 
measure for generalised anxiety disorder (GAD) and is used to monitor the severity of anxiety 
symptoms and response to treatment within IAPT services. It has been shown to be a reliable and 
valid measure of GAD (Spitzer et al., 2006). Each item is scored from “0" (not at all) to "3" (nearly 
every day). The maximum score for the GAD-7 is 21 with higher scores indicating higher levels of 
impairment. A score of 8 or more is used as a cut-off to identify clinical caseness in IAPT. Patients 
were classified as ‘recovered’ if their GAD-7 scores were above the clinical cut-off at the initial 
assessment and below the clinical cut-off at the last assessment. A change of 4 or more indicates 
reliable improvement/deterioration in anxiety symptoms in IAPT. The internal consistency of the 
GAD-7 in the IAPT sample was 0.8.   
       
 
Combined depression/anxiety symptoms 
As outlined in the IAPT manual (The National Collaborating Centre for Mental Health, 2018), patients 
were classified as recovered on measures of both depression and anxiety if they scored above the 
questionnaire cut point on either measure at the first assessment, and below the cutpoint on both 
questionnaire measures at the last assessment. Patients were classified as having shown reliable 




measure showed a reliable increase. Conversely, patients were considered to have reliably 
deteriorated if their scores for depression and/or anxiety increased by a reliable amount and neither 
measure showed a reliable decrease.  
 
4) Social functioning (assessed at initial assessment and at last clinical contact) 
Impairment in social functioning was assessed using the Work and Social Adjustment Scale (W&SAS) 
(Mundt et al., 2002). This is a five-item scale designed to measure the impact of a patient’s 
perceived mental health difficulties on their functioning (work, home management, social and 
leisure activities, private leisure activities, and relationships). Each item is scored on an eight-item 
Likert scale from “0” (not at all) to “8” (very severely). The maximum score for the W&SAS is 40 with 
higher scores indicating higher levels of impairment.  
 
Covariates 
Available covariates included in all models included age, gender, and area level deprivation score. 
Deprivation deciles are calculated by ranking areas in England from the most deprived to least 
deprived and dividing into 10 equal groups (higher scores = lower levels of deprivation). Additional 
covariates used in some analyses included baseline symptom score (for the outcome of interest) and 
total number of treatment sessions. Information about the specific covariates included in each 
analysis model are provided in the text/table footnotes.  
 
Statistical Analysis 
We first explored whether personality difficulties were associated with engagement with 
treatment. The remaining analyses were then restricted to those who completed the minimum 
number of treatment sessions. Primary outcomes included depression/anxiety recovery and reliable 
improvement (defined as a minimum reduction in symptoms; 6 for depression and 4 for anxiety). 




clinical contact (depression, anxiety and social functioning scores) and ii) reliable deterioration in 
symptoms (an increase of 6 or more symptoms for depression and 4 or more for anxiety).  
Associations were explored between the total number of personality difficulties recorded at 
baseline and each outcome using linear regression (for continuous outcome measures) and logistic 
regression (for binary outcomes). For the two primary outcome measures (recovery and reliable 
improvement), we conducted additional analysis to investigate associations with a binary SAPAS 
score (dichotomised at 3), with individual SAPAS items, and in the sub-sample (30%) whose SAPAS 
assessment was completed at the same time as their baseline PHQ-9 and GAD-7 ratings. We also 
investigated the possibility of effect modification of an association between personality difficulties 
and treatment response, by treatment received. We did this by testing for an interaction between 
the number of personality difficulties and treatment type (CBT/EST/PT) in predicting 
recovery/reliable improvement status, using the likelihood ratio test.  All analyses were conducted 






Sample description  
There were 3,689 participants with data on personality difficulties during the treatment episode. 
SAPAS scores were normally distributed (Supplementary Figure 1) with a mean of 4.3 (SD 1.9). The 
proportion of the sample endorsing individual SAPAS items ranged from 38.1% (depends on others a 
lot) to 84.9% (normally a worrier). The mean age of the sample was 44.5 years (SD 14.2) and 71.7% 
(n=2,645) were female. SAPAS scores were lower in females (difference in SAPAS -0.37, 95% CI -0.50 
to -0.24, P<0.001), in older patients (change in SAPAS per 1-year increase in age = -0.02, 95% CI -0.03 
to -0.02, P<0.001) and in those who lived in a less deprived area (change in SAPAS per 1-decile 
reduction in deprivation = -0.09, 95% CI -0.12 to -0.06, P<0.001). The most common treatment 
received was CBT (n=1,684, 45.7%), with 24.7% (n=912) of the sample receiving EST and 29.6% 
(n=1,092) receiving other PT. With regards to treatment allocation, there were no differences in 
SAPAS scores between those receiving CBT or EST (difference in SAPAS for EST vs CBT 0.10, 95%CI -
0.05 to 0.25, P=0.182), however those allocated to ‘other PT’ had fewer personality difficulties 
(difference in SAPAS for PT vs CBT -0.42 95%CI -0.56 to -0.28, P<0.001; PT vs EST -0.52, 95%CI -0.68 
to -0.36, P<0.001).  
 
Association between personality difficulties and baseline symptom scores  
Patients with a greater total number of personality difficulties had higher symptom scores at the first 
assessment across all measures (Table 1).  
 
Missing outcome data  
Outcome data was considered to be missing if the last assessment date for PHQ, GAD and W&SAS 
differed by more than 4 weeks. Of the 3,689 patients with SAPAS data, 3625 (98%) had end of 
treatment data on at least one outcome variable. The proportion with missing outcome data was 6% 




those with baseline data on social functioning. Compared to those with complete outcome data, 
patients who were missing data on at least one outcome variable completed fewer treatment 
sessions, and had a lower baseline score for depression and anxiety (Supplementary Table 2). There 
were no differences in demographics (age, gender, deprivation), SAPAS score, or baseline social 
functioning score.  
 
Association between personality difficulties and engagement with treatment   
The number of treatment sessions attended was positively skewed with a mean of 8.4 and a median 
of 8 sessions (range 1-40). Information on engagement with treatment (completed minimum 
number of treatment sessions) and relevant covariates (age, gender, deprivation decile, baseline 
depression and anxiety score) was available for over 99% (3,686/3,689) of patients. Only 7% failed to 
engage with treatment (n=255/3686). There was weak evidence to suggest that having a higher 
SAPAS score was associated with a reduced likelihood of engaging with treatment (OR per unit 
increase on SAPAS=1.07, 95% CI: 0.99 to 1.14, P=0.070), however the association did not remain 
following adjustment for covariates (OR=1.03, 95% CI= 0.95 to 1.10, P=0.516). The median time 
between the first and last assessment (for those who completed the minimum number of sessions) 
was 22 weeks for depression and 24 weeks for anxiety.  
 
Association between personality difficulties and IAPT treatment outcomes 
Recovery  
Among the patients who completed the minimum number of treatment sessions, 87% (3,002/3,433) 
met criteria for clinical caseness (i.e. reached a minimum symptom threshold) for depression at the 
initial assessment, 89% (3,049/3,433) for anxiety, and 93% (3,207/3,433) for either 
depression/anxiety. Of these, 48% of those scoring above the cut-off for  depression recovered (i.e. 
moved from a case to a non-case), 44% of those scoring above the cut-off for anxiety recovered, and 




sessions, deprivation decile and baseline symptom score) higher SAPAS scores were associated with 
a reduced likelihood of recovery (Table 2 (OR per unit increase on SAPAS: depression=0.87, 95% CI 
0.84 to 0.91, P<0.001; anxiety= 0.86, 95% CI 0.82 to 0.90, P<0.001; depression and anxiety=0.87, 95% 
CI 0.83 to 0.91, P<0.001). Table 3 shows associations between personality difficulties and recovery 
status separately for those receiving CBT, EST and other PT. We did not find statistical evidence for 
an interaction with treatment type (P=0.727 for depression; P=0.585 for anxiety; P=0.472 for 
depression and anxiety). 
 
Reliable improvement in symptom scores 
Among the patients who completed the minimum number of treatment sessions, 54% (1,763/3,244) 
had a reliable improvement in depression scores, 59% (1,919/3,315) had a reliable improvement in 
anxiety scores, and 66% (2,107/3,184) reliably improved on at least one measure. In adjusted 
analysis (adjusted for age, gender, number of sessions, deprivation decile and baseline symptom 
score) higher SAPAS scores were associated with a reduced likelihood of reliable improvement 
(Table 2) (OR per unit increase on SAPAS: depression= 0.88, 95% CI 0.84 to 0.92, P<0.001; anxiety= 
0.85, 95% CI 0.82 to 0.89, P<0.001; either depression or anxiety= 0.86, 95% CI 0.82 to 0.90, P<0.001). 
Table 3 shows associations between personality difficulties and reliable improvement status 
separately for those receiving CBT, EST and other PT. We did not find statistical evidence of an 
interaction with treatment type (P=0.342 for depression; P=0.421 for anxiety; P=0.186 for 
depression or anxiety).  
 
Change in symptom scores between first and last assessment  
On average, across the sample, there was improvement in all domains between the first and last 
assessments (Table 4). In adjusted analyses (adjusted for age, gender, number of sessions and 
deprivation decile), the change in anxiety and functioning scores was lower for those with a greater 




-0.06 to 0.01, P=0.094; functioning: B= -0.46, standardised beta =-0.09, 95% CI -0.14 to -0.04, 
P=<0.001), however for anxiety, findings did not reach conventional levels of statistical significance. 
We did not find evidence for an association with depression scores, although the coefficient point 
estimate was consistent with a reduced change in score with increasing personality difficulties (B = -
0.06, standardised beta = -0.02, 95% CI -0.05 to 0.02, P=0.360). 
 
Reliable deterioration in symptom scores 
Among the patients who completed the minimum number of treatment sessions, 3% had a reliable 
deterioration in depression scores (98/3,244), 6% had a reliable deterioration in anxiety scores 
(187/3,315), and 6% (201/3,184) had a reliable deterioration on at least one measure. Higher SAPAS 
scores were associated with an increased likelihood of reliable deterioration (adjusted OR per unit 
increase on SAPAS: depression=1.20, 95% CI 1.07 to 1.36, P=0.003; anxiety= 1.23, 95% CI 1.12 to 
1.34, P<0.001; either depression or anxiety=1.21, 95% CI 1.11 to 1.32, P<0.001).  
 
Associations with categorical SAPAS measure  
Additional analyses explored associations between primary outcome measures and a binary SAPAS 
score, dichotomised at 3, which indicates high risk of personality disorder (Moran et al., 2003). The 
proportion of the sample  that endorsed 3 or more personality difficulties was 81% (2,771/3,433). 
The proportion with high SAPAS scores was 83% in the CBT group, 83% in the EST group and 75% in 
the other PT group. Compared to those with low SAPAS scores, those with high scores had lower 
odds of recovery (adjusted OR per unit increase on SAPAS: depression= 0.64, 95% CI 0.52 to 0.78; 
anxiety= 0.60, 95% CI 0.49 to 0.73; depression and anxiety= 0.65, 95% CI 0.53 to 0.79) and reliable 
improvement (adjusted OR per unit increase on SAPAS: depression = 0.73, 95% CI 0.60 to 0.88; 
anxiety= 0.64, 95%CI 0.53 to 0.77; either depression or anxiety= 0.67, 95%CI 0.55 to 0.82).  
 




SAPAS items 1 (difficulty making and keeping friends), 2 (usually a loner), 3 (difficulty trusting 
others), 6 (normally a worrier) and 7 (depends on others a lot) were associated with reduced 
likelihood of recovery and reliable improvement (Table 5). Patients who endorsed SAPAS items 4 
(loses temper easily) and 8 (generally a perfectionist) were also less likely to show reliable 
improvement.  
 
Sensitivity analysis accounting for differential timing of SAPAS rating  
In order to account for the fact that in the total sample, the timing of SAPAS assessment varied, with 
only 30% having synchronised ratings of personality, depression and anxiety symptoms, we 
conducted a sensitivity analysis in a restricted sample of patients who had SAPAS data recorded at 
the same time as their baseline measures of depression and anxiety symptoms.  The results of this 
analysis were consistent with the main analysis: compared to those with low SAPAS scores, those 
with higher scores had lower odds of recovery (adjusted OR per unit increase on SAPAS: depression= 
0.88, 95% CI 0.81 to 0.95; anxiety= 0.87, 95% CI 0.81 to 0.95; depression and anxiety= 0.90, 95%CI 
0.83 to 0.98) and reliable improvement (adjusted OR per unit increase on SAPAS: depression = 0.90, 
95% CI 0.84 to 0.98; anxiety= 0.93, 95%CI 0.86 to 1.00; either depression or anxiety= 0.93, 95%CI 
0.86 to 1.00). We did not find statistical evidence of an interaction with treatment type in this 






We investigated the association between personality difficulties and treatment response in a large 
sample of IAPT attendees with common mental disorder. Higher SAPAS scores were associated with 
less favourable treatment outcomes; the odds of recovery and reliable improvement were reduced 
by 13% and 14% respectively for each additional personality difficulty experienced. Those who 
endorsed high levels of difficulties (3+) were over 30% less likely to recover or reliably improve. Our 
findings suggest that while individuals with personality difficulties experience an overall reduction in 
symptoms following IAPT treatment, the absolute change in anxiety and social functioning scores is 
reduced. A greater number of personality difficulties was also associated with an increased risk of 
reliable deterioration in symptoms, although this outcome was experienced by only a small 
proportion of patients. SAPAS scores were not related to treatment engagement.   
 
Comparison with other studies  
The majority of those allocated to high-intensity IAPT treatments had personality difficulties - 81% of 
patients endorsing more than 3 symptoms, indicating high risk of personality disorder. This figure is 
in line with other data (Hepgul et al., 2016), and suggests that many patients referred to IAPT have 
complex needs, which may not be adequately addressed with currently available IAPT treatments.  
 Patients with personality difficulties had more severe psychopathology at baseline with 
higher depression and anxiety symptoms, and lower levels of social functioning. Yet, even after 
adjustment for these baseline differences, personality difficulties were associated with poorer 
outcomes at end of treatment, including a reduced risk of recovery and reliable improvement in 
symptoms. This is consistent with findings from a meta-analytic review, which found that the 
presence of co-morbid personality disorder (PD) doubled the likelihood of treatment non-response 
for depressive disorders (Newton-Howes et al., 2014). Moreover, this association has been found 




combination therapy (Newton-Howes et al., 2006, Gorwood et al., 2010). Similar adverse effects of 
PD on treatment outcome have also been found for patients with anxiety disorders. However, not all 
findings have been consistent (van Bronswijk et al., 2018, Kampman et al., 2008, Joyce et al., 2007), 
for example a recent randomised controlled trial found no negative effect of PD on the effectiveness 
of psychological treatment for patients with Major Depressive Disorder (van Bronswijk et al., 2018).  
 Our findings are also in line with the only other study of personality difficulties and IAPT 
treatment response (Goddard et al., 2015). We have shown that this association is also present in a 
different geographical region, suggesting the existence of a wider phenomenon. Furthermore, we 
have provided several important extensions to previous work by i) investigating associations with 
individual personality difficulties, ii) exploring whether there are differential effects according to 
treatment type, and iii) investigating the effect of personality difficulties on reliable improvement. 
This latter point is particularly important, as individuals may show improvement in symptoms 
without moving below the caseness threshold. Furthermore, cases scoring just above the threshold 
may only decrease by a small amount yet would still be classified as having recovered. Compared 
with the only other study in this field, our sample is also considerably larger (previous study n=1249) 
and treatment was more homogenous, as we exclusively focused on individuals who had been 
allocated to high intensity treatments delivered by a trained therapist. Further research is needed to 
investigate whether personality disorders are also associated with treatment response in those 
patients with milder symptoms, allocated to low intensity treatments.  
We did not find evidence of an interaction between personality difficulties and treatment 
type, suggesting that currently, there is no evidence that a specific type of IAPT treatment is likely to 
be more beneficial for patients with personality difficulties. This finding needs replication, as our 
analysis may be underpowered to detect an interaction, however the results are consistent with a 
recent systematic review (Newton-Howes et al., 2014). Some research has previously suggested that 
response to particular therapies may be associated with different features of PD; for example Van 




cognitive therapy as opposed to interpersonal therapy. Given that the SAPAS is not a diagnostic tool, 
we were unable to explore differential outcomes according to PD type or cluster of PD in this study. 
However, we did find that certain personality features were specifically associated with poorer 
treatment outcome. In particular, those personality difficulties characteristic of cluster A and C 
disorders (i.e. difficulties with forming and maintaining relationships, being a loner or a worrier, or 
being dependent on others) were associated with a less favourable treatment outcome. In contrast, 
we did not find evidence for an association between impulsivity (a trait characteristic of cluster B 
disorders) and odds of recovery or reliable improvement. Whilst some research suggests that 
impulsive individuals are more likely to disengage from clinical tasks and thus have worse treatment 
outcomes(Martino et al., 2012, López-Torrecillas et al., 2014), we found no such association among a 
large treatment sample presenting for help with common mental disorder. This is important as the 
finding may help to instil confidence among staff working in IAPT services with patients presenting 
with impulsive personality characteristics. If replicated, the findings also suggest that screening for 
the presence of underlying personality difficulties may help IAPT services to establish alternative, 
more effective care pathways for patients with these difficulties, who inevitably have more complex 
patterns of relating to practitioners.  
 
Strengths and limitations  
To the best of our knowledge, this is the first study to investigate the relationship between specific 
personality difficulties and treatment response within the IAPT service, and to explore whether 
effects are moderated by treatment type. The study involved a large sample of IAPT attendees 
allocated to high-intensity treatment. Associations were explored with a range of outcomes and 
analyses were adjusted for relevant confounding variables.  
The findings need to be interpreted in light of the following limitations. Firstly, data on 
personality difficulties were collected via self-report, which could result in an overestimation of 




been validated for use in both clinical and population-based samples (Moran et al., 2003, Fok et al., 
2015, Hesse and Moran, 2010) and has good diagnostic specificity when compared with clinical 
interview (Moran et al., 2003). The measure is also practical for use in a busy clinical setting as it is 
quick to administer. Secondly, differences were found between individuals with and without 
complete outcome data, and it is possible this may have led to bias. SAPAS data were only available 
for approximately half of the sample and only 30% had data recorded at baseline. The low response 
is due to administrative reasons as it took time to implement the measure into routine practice and 
it is possible that missing data could introduce bias if those with higher SAPAS scores were more or 
less likely to complete the questionnaire. Notwithstanding, sensitivity analysis on the subsample 
with data collected at baseline produced consistent results, supported our main findings. Our 
analytic sample (those with SAPAS data) also included more female and older patients which may 
limit the generalisability of our results. Third, although the level of personality difficulties was the 
same among those allocated to CBT and EST, those allocated to ‘other PT’ treatment were more 
likely to have lower SAPAS scores. It is possible that this could influence the results if treatments are 
not equally effective. Fourth, we adjusted for several key confounders, but residual confounding 
remains a possibility. Finally, information was not available on other clinically important outcomes 
such as self-harm and suicidal thoughts. Investigating the relationship between personality 
difficulties and a broader range of outcomes would be a useful avenue for further research.   
 
Clinical implications  
Personality difficulties are highly prevalent among patients accessing high-intensity treatments 
within the IAPT service. Our findings suggest that personality difficulties may be associated with 
treatment outcome and should be routinely assessed before starting treatment. To do so, staff 
working within IAPT services must be adequately trained in the assessment of individuals with 
personality difficulties, including an understanding of how these difficulties may impact on clinical 




personality difficulties respond to treatment (as indicated by change scores), the extent of 
improvement in symptoms is reduced. This is particularly the case for patients with 3 or more 
personality difficulties, who are over 30% less likely to recover or show reliable improvement in 
symptoms. Although not a common occurrence (~6% of the sample), personality difficulties were 
also associated with an increased risk of deterioration in symptoms.  
Whilst the idea of ‘tailoring’ IAPT treatment for individuals with personality difficulties may 
be appealing, the feasibility of achieving this in practice is uncertain. Indeed, given that the 
commissioning framework for IAPT services is so precisely defined, we would argue that in practice, 
IAPT services are not set up to provide such tailored treatment. Clearly, identifying the right setting 
to provide scalable treatment for this large population of individuals remains a huge challenge for 
the Health service. If replicated, our findings suggest that IAPT services may need to adopt different, 
change-sensitive outcome measures to better capture treatment response among patients with 
personality difficulties. Moreover, the intensity of treatment and levels of therapeutic expertise and 
supervision are likely to require modification if IAPT services are to optimise outcomes for this group 
of patients. 
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Table 1: Association between SAPAS score and baseline symptom scores  
 
 
 Unadjusted Adjusted  
B (95%CI) Standardised 
 Beta (95%CI) 
P B(95%CI) Standardised 
 Beta (95%CI) 
P 
Depression score (n=3687)  0.92 (0.83, 1.02) 0.30 (0.26, 0.33) <0.001 0.96 (0.86, 1.06) 0.31 (0.27, 0.34) <0.001 
Anxiety score (n=3687) 0.79 (0.71, 0.87) 0.30 (0.27, 0.33) <0.001 0.79 (0.71, 0.87) 0.30 (0.27, 0.34) <0.001 
Functioning score (n=2,460) 1.12 (0.95, 1.29) 0.25 (0.21, 0.28) <0.001 1.13 (0.96, 1.31) 0.25 (0.21, 0.29) <0.001 
Adjusted for age, gender and deprivation decile 
Unstandardised coefficients represents the change in dependent variable per 1-unit increase in SAPAS score; standardised coefficients represent the SD 










OR (95%CI)  
P Value  Adjusted 
OR (95%CI)  
P Value  
Recovery †     
  Depression (n=3,000) 0.82 (0.79, 0.85) <0.001 0.87 (0.84, 0.91) <0.001 
  Anxiety (n=3,047) 0.81 (0.78, 0.85) <0.001 0.86 (0.82, 0.90) <0.001 
  Depression and anxiety (n=3,205) ‡ 0.80 (0.77, 0.84) <0.001 0.87 (0.83, 0.91) <0.001 
 
Reliable improvement        
  Depression (n=3,242) 0.97 (0.94, 1.01) 0.147 0.88 (0.84, 0.92) <0.001 
  Anxiety (n=3,313) 0.94 (0.91, 0.98) 0.001 0.85 (0.82, 0.89) <0.001 
  Depression or anxiety (n=3,182) 0.93 (0.90, 0.97) 0.001 0.86 (0.82, 0.90) <0.001 
Adjusted for age, gender, number of sessions, deprivation decile and baseline score (of outcome variable). n=2 with missing data on confounders  
† Association with recovery among those meeting criteria for clinical caseness at first assessment  
‡  Recovery among those meeting criteria for clinical caseness for either depression or anxiety at first assessment  












Table 3: Association between SAPAS score, recovery and reliable improvement according to treatment group    
 
 Cognitive Behavioural 
Therapy 






P Value  Adjusted 
OR (95%CI)  
P Value  Adjusted 
OR (95%CI)  
P Value  
Recovery †       
  Depression  0.88 (0.83, 0.94) <0.001 0.88 (0.80, 0.96) 0.006 0.86 (0.79, 0.93) <0.001 
  Anxiety  0.85 (0.79, 0.90) <0.001 0.89 (0.81, 0.97) 0.011 0.85 (0.79, 0.92) <0.001 
  Depression and anxiety ‡ 0.86 (0.81, 0.92) <0.001 0.90 (0.82, 0.99) 0.030 
 
0.86 (0.79, 0.93) <0.001 
Reliable improvement          
  Depression  0.84 (0.78, 0.89) <0.001 0.93 (0.85, 1.02) 0.110 0.91 (0.85, 0.98) 0.013 
  Anxiety  0.83 (0.78, 0.89) <0.001 0.91 (0.84, 0.99) 0.040 0.84 (0.78, 0.91) <0.001 
  Depression or anxiety  0.82 (0.77, 0.88) <0.001 0.92 (0.84, 1.02) 0.101 0.87 (0.81, 0.94) <0.001 
 
Adjusted for age, gender, number of sessions, deprivation decile and baseline score (of outcome variable). n=2 with missing data on confounders 
† Association with recovery among those meeting criteria for clinical caseness at first assessment  
‡ Recovery among those meeting criteria for clinical caseness for either depression or anxiety at first assessment  





Table 4: Association between SAPAS score and change in symptom score between first and last assessment   
 
 Treatment Outcomes † Score at 
first 
assessment  
Score at last 
assessment  
Unadjusted Adjusted 
B (95%CI)  Standardised 
Beta (95%CI)  
P 
Value 
B (95%CI)  Standardised 
Beta (95%CI)  
P 
value  
Depression score  
mean (SD), (n=3,242) 
16.8 (5.9) 10.3 (7.1) -0.09 (-0.21, 0.03)  -0.02 (-0.06, 0.01)  0.158 -0.06 (-0.19, 0.07)  -0.02 (-0.05, 0.02)  0.360 
Anxiety score  
mean (SD), (n=3,313) 
14.3 (4.9) 9.1 (6.1) -0.10 (-0.21, 0.01)  -0.03 (-0.06, 0.00)  0.078 -0.10 (-0.21, 0.02)  -0.03 (-0.06, 0.01)  0.094 
Functioning score  
mean (SD), (n=1,782) 
20.0 (8.4) 14.3 (9.8) -0.44 (-0.69, -0.20)  -0.08 (-0.13, -0.04)  <0.001 -0.46 (-0.71, -0.21)  -0.09 (-0.14, -0.04)  <0.001 
Adjusted for age, gender, number of sessions and deprivation decile. n=2 with missing data on confounders 
† Variables recoded so that positive values indicate more improvement in symptoms and negative values indicate less improvement in symptoms   
Unstandardised coefficients represents the change in outcome per 1-unit increase in SAPAS score; standardised coefficients represent the SD change in 






Table 5: Association between individual SAPAS items, recovery and reliable improvement     
 
 Treatment Outcomes Unadjusted Adjusted  
OR (95%CI) P Value OR (95%CI) P Value 
Recovery (depression and anxiety) † 
Item 1: Difficulty making and keeping friends 
Item 2: Usually a loner  
Item 3: Trusting others 
Item 4: Normally loses temper easily 
Item 5: Normally impulsive 
Item 6: Normally a worrier 
Item 7: Depends on others a lot 
Item 8: Generally a perfectionist  
 
0.51 (0.44, 0.59) 
0.53 (0.47, 0.63) 
0.60 (0.52, 0.70) 
0.74 (0.64, 0.85) 
0.92 (0.80, 1.06) 
0.70 (0.57, 0.86) 
0.61 (0.52, 0.70) 











0.64 (0.55, 0.74) 
0.66 (0.56, 0.76) 
0.78 (0.66, 0.91) 
0.89 (0.76, 1.04) 
1.02 (0.88, 1.19) 
0.80 (0.65, 0.99) 
0.68 (0.58, 0.79) 










Reliable improvement (depression or anxiety) 
Item 1: Difficulty making and keeping friends 
Item 2: Usually a loner  
Item 3: Trusting others 
Item 4: Normally loses temper easily 
Item 5: Normally impulsive 
Item 6: Normally a worrier 
Item 7: Depends on others a lot 
Item 8: Generally a perfectionist  
 
0.70 (0.61, 0.82) 
0.75 (0.64, 0.86) 
0.89 (0.76, 1.03) 
0.95 (0.82, 1.10) 
1.10 (0.95, 1.28) 
0.99 (0.81, 1.22) 
0.83 (0.72, 0.97) 











0.59 (0.50, 0.69) 
0.65 (0.55, 0.76)  
0.72 (0.62, 0.85) 
0.84 (0.72, 0.98) 
1.04 (0.89, 1.21) 
0.83 (0.67, 1.03) 
0.76 (0.65, 0.89) 










† Recovery among those meeting criteria for clinical caseness for either depression or anxiety at first assessment  
Adjusted for age, gender, number of sessions, deprivation decile and baseline depression and anxiety symptom scores. n=2 with missing data on confounders 
OR represents the odds of outcome per 1-unit increase in SAPAS score 
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